Matricelf Ltd (TLV:MTLF)
Israel · Delayed Price · Currency is ILS · Price in ILA 260.00
-7.80 (-2.91%)
Jul 14, 2026, 5:24 PM IDT
Matricelf Market Cap
Matricelf has a market cap or net worth of 78.32 million as of July 14, 2026. Its market cap has increased by 74.55% in one year.
Market Cap
78.32M
Enterprise Value
58.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
260.00
Market Cap Chart
Since June 20, 2021, Matricelf's market cap has increased from 62.00M to 78.32M, an increase of 26.32%. That is a compound annual growth rate of 4.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 77.24M | -49.17% |
| Dec 31, 2025 | 151.94M | 156.50% |
| Dec 31, 2024 | 59.23M | 18.14% |
| Dec 31, 2023 | 50.14M | -7.15% |
| Dec 29, 2022 | 54.00M | -47.98% |
| Dec 30, 2021 | 103.80M | 67.43% |
| Jun 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geffen Residence & Renewal | 335.28M |
| Bonus BioGroup | 320.07M |
| Clal Biotechnology Industries | 42.51M |
| BioLineRx | 39.31M |
| BioLight Life Sciences | 34.70M |
| Can-Fite BioPharma | 21.36M |
| XTL Biopharmaceuticals | 19.66M |
| Purple Biotech | 18.65M |